Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $44.7B |
| FY2017, ended Dec 31, 2017 | $50.7B |
| FY2018, ended Dec 31, 2018 | $39.2B |
| FY2019, ended Dec 31, 2019 | $49.0B |
| FY2020, ended Dec 31, 2020 | $30.6B |
| FY2021, ended Dec 31, 2021 | $31.8B |
| FY2022, ended Dec 31, 2022 | $48.3B |
| FY2023, ended Dec 31, 2023 | $57.0B |
| FY2024, ended Dec 31, 2024 | $46.4B |
| FY2025, ended Dec 31, 2025 | $51.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $99.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $84.3B |
| FY2017, ended Dec 31, 2017 | $102B |
| FY2018, ended Dec 31, 2018 | $111B |
| FY2019, ended Dec 31, 2019 | $107B |
| FY2020, ended Dec 31, 2020 | $64.1B |
| FY2021, ended Dec 31, 2021 | $111B |
| FY2022, ended Dec 31, 2022 | $170B |
| FY2023, ended Dec 31, 2023 | $147B |
| FY2024, ended Dec 31, 2024 | $143B |
| FY2025, ended Dec 31, 2025 | $132B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $168B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.55B |
| FY2017, ended Dec 31, 2017 | $5.11B |
| FY2018, ended Dec 31, 2018 | $5.59B |
| FY2019, ended Dec 31, 2019 | $3.08B |
| FY2020, ended Dec 31, 2020 | −$3.98B |
| FY2021, ended Dec 31, 2021 | $1.32B |
| FY2022, ended Dec 31, 2022 | $11.0B |
| FY2023, ended Dec 31, 2023 | $7.01B |
| FY2024, ended Dec 31, 2024 | $2.12B |
| FY2025, ended Dec 31, 2025 | $4.40B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $12.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.71B |
| FY2017, ended Dec 31, 2017 | $3.12B |
| FY2018, ended Dec 31, 2018 | $3.02B |
| FY2019, ended Dec 31, 2019 | $1.61B |
| FY2020, ended Dec 31, 2020 | $2.51B |
| FY2021, ended Dec 31, 2021 | $3.15B |
| FY2022, ended Dec 31, 2022 | $6.13B |
| FY2023, ended Dec 31, 2023 | $3.32B |
| FY2024, ended Dec 31, 2024 | $1.74B |
| FY2025, ended Dec 31, 2025 | $1.12B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $5.85B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.1B |
| FY2017, ended Dec 31, 2017 | $10.1B |
| FY2018, ended Dec 31, 2018 | $11.2B |
| FY2019, ended Dec 31, 2019 | $11.8B |
| FY2020, ended Dec 31, 2020 | $15.9B |
| FY2021, ended Dec 31, 2021 | $14.4B |
| FY2022, ended Dec 31, 2022 | $17.2B |
| FY2023, ended Dec 31, 2023 | $19.4B |
| FY2024, ended Dec 31, 2024 | $20.1B |
| FY2025, ended Dec 31, 2025 | $19.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $18.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 24.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 518M |
| FY2017, ended Dec 31, 2017 | 501M |
| FY2018, ended Dec 31, 2018 | 455M |
| FY2019, ended Dec 31, 2019 | 439M |
| FY2020, ended Dec 31, 2020 | 437M |
| FY2021, ended Dec 31, 2021 | 438M |
| FY2022, ended Dec 31, 2022 | 464M |
| FY2023, ended Dec 31, 2023 | 428M |
| FY2024, ended Dec 31, 2024 | 408M |
| FY2025, ended Dec 31, 2025 | 401M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 390M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.04B | $156M | — |
| FY2017, ended Dec 31, 2017 | $1.59B | $142M | $35.0M |
| FY2018, ended Dec 31, 2018 | $4.64B | $100M | $39.0M |
| FY2019, ended Dec 31, 2019 | $1.65B | $169M | $32.0M |
| FY2020, ended Dec 31, 2020 | $443M | $127M | $8.00M |
| FY2021, ended Dec 31, 2021 | $0 | $144M | $26.0M |
| FY2022, ended Dec 31, 2022 | $1.51B | $210M | $103M |
| FY2023, ended Dec 31, 2023 | $4.01B | $297M | $123M |
| FY2024, ended Dec 31, 2024 | $3.45B | $210M | $86.0M |
| FY2025, ended Dec 31, 2025 | $1.21B | $220M | $107M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.19B | — | $169M |
Valuation
At current price- Market Cap
- $105B
- P/E
- 8.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.6×
- Price / Book
- 3.1×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $168B
- Revenue Growth YoY
- 27.5%
- Revenue CAGR 3Y
- −8.0%
- Revenue CAGR 5Y
- 15.6%
- EPS Growth YoY
- 740%
- Net Income Growth YoY
- 736%
Profitability
Trailing 12 months- Gross Margin
- 15.1%
- Operating Margin
- —
- Net Margin
- 7.5%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 41.1%
Earnings
Trailing 12 months- Net Income
- $12.6B
- EPS (diluted)
- $31.18
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $5.85B
- Total Debt
- $18.5B
- Net Debt
- $12.7B
- Total Assets
- $86.0B
- Total Liabilities
- $50.5B
- Shareholders' Equity
- $34.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $15.0B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 1.9%
- Dividend / Share
- $5.01
- Beta (5Y)
- 0.71
Every ratio is calculated from the company’s reported figures.